1. Home
  2. HTBK vs LXRX Comparison

HTBK vs LXRX Comparison

Compare HTBK & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTBK
  • LXRX
  • Stock Information
  • Founded
  • HTBK 1997
  • LXRX 1995
  • Country
  • HTBK United States
  • LXRX United States
  • Employees
  • HTBK N/A
  • LXRX N/A
  • Industry
  • HTBK Major Banks
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTBK Finance
  • LXRX Health Care
  • Exchange
  • HTBK Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • HTBK 586.0M
  • LXRX 650.7M
  • IPO Year
  • HTBK 1998
  • LXRX 2000
  • Fundamental
  • Price
  • HTBK $10.65
  • LXRX $0.98
  • Analyst Decision
  • HTBK Buy
  • LXRX Buy
  • Analyst Count
  • HTBK 3
  • LXRX 2
  • Target Price
  • HTBK $11.50
  • LXRX $6.00
  • AVG Volume (30 Days)
  • HTBK 360.0K
  • LXRX 4.3M
  • Earning Date
  • HTBK 10-24-2024
  • LXRX 11-12-2024
  • Dividend Yield
  • HTBK 4.88%
  • LXRX N/A
  • EPS Growth
  • HTBK N/A
  • LXRX N/A
  • EPS
  • HTBK 0.71
  • LXRX N/A
  • Revenue
  • HTBK $169,172,000.00
  • LXRX $5,229,000.00
  • Revenue This Year
  • HTBK N/A
  • LXRX $1,212.46
  • Revenue Next Year
  • HTBK $5.08
  • LXRX $219.10
  • P/E Ratio
  • HTBK $15.08
  • LXRX N/A
  • Revenue Growth
  • HTBK N/A
  • LXRX 886.60
  • 52 Week Low
  • HTBK $7.66
  • LXRX $0.97
  • 52 Week High
  • HTBK $11.01
  • LXRX $3.73
  • Technical
  • Relative Strength Index (RSI)
  • HTBK 59.40
  • LXRX 25.78
  • Support Level
  • HTBK $10.49
  • LXRX $1.01
  • Resistance Level
  • HTBK $11.01
  • LXRX $1.35
  • Average True Range (ATR)
  • HTBK 0.32
  • LXRX 0.12
  • MACD
  • HTBK 0.08
  • LXRX -0.06
  • Stochastic Oscillator
  • HTBK 76.92
  • LXRX 0.43

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two segments, namely Banking and Factoring. The bank generates its revenue from the Banking segment.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Share on Social Networks: